Modified saline abortion for medically high-risk patients
Perry, G.; Schulman, H.; Wong, T.C.
Obstetrics and Gynecology 44(4): 571-578
1974
ISSN/ISBN: 0029-7844 PMID: 4414703 Document Number: 82444
Document emailed within 1 workday
Related Documents
Virk, J.; Zhang, J.; Olsen, J.ør. 2007: Medically-induced abortion and risk of reproductive failures in subsequent pregnancy Ugeskrift for Laeger 169(50): 4363-4365Peterss, S.; Beckmann, E.; Bhandari, R.; Hadem, J.; Hagl, C.; Khaladj, N.; Haverich, A.; Kutschka, I. 2015: Aortic Valve Replacement in Patients with End-Stage Liver Disease: a Modified Perfusion Concept in High-Risk Patients Journal of Heart Valve Disease 24(3): 302-309
Calabrò, P.; Bianchi, R.; Caprile, M.; Sordelli, C.; Cappelli Bigazzi, M.; Palmieri, R.; Gigantino, G.; Limongelli, G.; Capozzi, G.; Cuomo, S.; Calabrò, R. 2010: Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography Minerva Cardioangiologica 58(1): 35-40
Puri, S.; Eleem, F.; Schulman, H. 1976: A histologic study of the placentas of patients with saline- and prostaglandin-induced abortion Obstetrics and Gynecology 48(2): 216-220
Fischbein, A.; Sharma, O.K.; Valciukas, J.A.; Bekesi, J.G.; Buschman, F.; Apell, G.; Kohn, M.; Boesch, R.R.; Teirstein, A.; Selikoff, I.J. 1985: Urinary excretion of modified nucleosides in patients with acquired immune deficiency syndrome (AIDS) and individuals at high risk of AIDS Cancer Detection and Prevention 8(1-2): 271-277
Nilas, L.; Ottesen, B.S. 2006: Should early abortion be treated medically? Ugeskrift for Laeger 168(3): 293-294
Hermanides, R.S.; Ottervanger, J.P.; ten Berg, J.M.; Gosselink, A.T.M.; van Houwelingen, G.; Dambrink, J.-H.E.; Stella, P.R.; Hamm, C.; van 't Hof, A.W.J. 2012: Net clinical benefit of prehospital glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction and high risk of bleeding: effect of tirofiban in patients at high risk of bleeding using CRUSADE bleeding score Journal of Invasive Cardiology 24(3): 84-89
Adams, E.D.; Cooper, B.H. 1974: Evaluation of a modified Wickerham medium for identifying medically important yeasts American Journal of Medical Technology 40(9): 377-388
Majeed, A.W.; Reed, M.W.; Ross, B.; Peacock, J.; Johnson, A.G. 1997: Gallstone removal with a modified cholecystoscope: an alternative to cholecystectomy in the high-risk patient Journal of the American College of Surgeons 184(3): 273-280
Dominguez de Villota, E. 1973: Complication of hypertonic saline induction of abortion Heart and Lung: the Journal of Critical Care 2(1): 116-121
Cheng, M.C.; Ratnam, S.S. 1971: Intrauterine injection of 20 per cent saline for inducing abortion Singapore Medical Journal 12(5): 259-263
Adachi, A.; Wilson, L.; Herzig, N. 1977: Prostaglandin F2alpha, hypertonic saline, and oxytocin in midtrimester abortion New York State Journal of Medicine 77(1): 46-49
Sharma, S.K.; Gupta, V.; Kadhiravan, T.; Banga, A.; Seith, A.; Kumar, A.; Saxena, R.; Thabah, M.M.; Gulati, V.; Bhatia, I.; Kavimandan, A.A. 2009: A prospective study of risk factor profile and incidence of deep venous thrombosis among medically-ill hospitalized patients at a tertiary care hospital in northern India Indian Journal of Medical Research 130(6): 726-730
Ivanov, P.; Komsa-Penkova, R.; Ivanov, I.; Konova, E.; Kovacheva, K.; Stoĭkov, S.; Popov, I. 2008: High risk of recurrent spontaneous abortion during second trimester in women carriers of polymorphism A2 in platelet glycoprotein IIb/IIIa Akusherstvo i Ginekologiia 47(4): 3-9
Holmdahl, T.H.; Johansson, E.D. 1971: Plasma progesterone during abortion induced by intra-amniotic hypertonic saline Acta Obstetricia et Gynecologica Scandinavica. Supplement 9: Suppl 9: 48
Nozar, M.; Fiol, V.; Gorgoroso, M.; Labandera, A.; Stapff, C.; Briozzo, L. 2009: O689 Misoprostol used as abortion method under a risk reduction strategy to prevent maternal deaths associated with unsafe abortion (health initiatives against unsafe abortion) International Journal of Gynecology and Obstetrics 107: S290-S291
Balwierz, W.; Moryl-Bujakowska, A.; Skoczeń, S.; Pawińska, K.; Balcerska, A.; Płoszyńska, A.; Chybicka, A.; Dobaczewski, G.; Juszczak, K.; Wachowiak, J.; Derwich, K.; Kowalczyk, J.; Wiśniewska-Slusarz, H.; Matysiak, Mł.; Krauze, A.; Rokicka-Milewska, R.; Pawelec, K.; Sońta-Jakimczyk, D.; Łuszczyńska, A.; Tomaszewska, R.; Wysocki, M.; Styczyński, J.; Swiatkiewicz, V. 2003: Advances in the treatment of children with high risk acute lymphoblastic leukemia (ALL) treated with modified "NEW YORK" protocols between 1987 and 2002 Przeglad lekarski 60 Suppl. 5: 13-16
Adem, C.; Jenkins, R.B.; Capron, Fédérique.; Stoppa-Lyonnet, D. 2004: High-risk lesions in high-risk women: a high-risk formalin-based biology! Journal of clinical oncology: official journal of the American Society of Clinical Oncology 22(6): 1159-61; author reply 1161-2
Hanada, N.; Tanaka, S.; Takahata, T.; Sato, A. 2014: Use of granulocyte-colony stimulating factor(G-CSF)in patients with cancer at high risk of febrile neutropenia on the basis of high age and complications, recommendations for patients receiving radiotherapy, and adverse events because of G-CSF Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(6): 702-706
Gupta, I.; Mahajan, U. 1990: A comparison of extra-amniotic physiological saline and ethacridine dye instillation for induction of mid-trimester abortion National Medical Journal of India 3(3): 110-112